Research Priorities

NEA funds forward thinking basic, clinical and translational adult and pediatric eczema research guided by the five research priorities established by our Scientific & Medical Advisory Council:

• Cutting-Edge Basic & Translational Science
  Innovative investigations of targets, pathways or technologies that will advance understanding of the pathophysiology or natural history of eczema, and potentially lead to novel or enhanced therapeutic/preventative areas of exploration or application.
• Eczema Heterogeneity: Novel Insights
  Projects aimed at advancing understanding of the underlying factors contributing to the diversity of eczema clinical presentation, treatment response and comorbidities.
• Innovations in Clinical Practice & Care
  Studies addressing approaches to facilitate optimal identification and treatment of eczema and associated comorbidities in all health care settings to enhance patient-reported and patient-centric outcomes.
• Understanding & Alleviating Disease Burden
  Insightful proposals that identify, quantify or aim to reduce aspects of eczema burden that negatively affect patient or family/caregiver quality of life (including lifestyle, academic/occupational, or economic impacts) based on patient population, treatment approach, etc.
• Eczema Prevention
  Novel investigations into the potential risk factors and strategies of primary eczema prevention at all ages.